BRIEF-Intellipharmaceutics/ Par to commercially launch 15 and 30 mg generic Focalin XR
Nov 18 (Reuters) - Intellipharmaceutics International Inc : * / Par to make immediate commercial launch of 15 and 30 mg generic Focalin
XR(R) * FDA granted final approval of dexmethylphenidate hydrochloride
extended-release capsules for 15 and 30 mg strengths * Co's dexmethylphenidate hydrochloride extended-release capsules 5, 10, 20 and
40 mg strengths were also tentatively FDA approved * Source text for Eikon * Further company coverage
© Thomson Reuters 2017 All rights reserved.